Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
Jim Cramer’s guide to investing: What do you do with a hot stock?
Sooner or later, virtually all hot stocks implode, said CNBC’s Jim Cramer. And according to him, it’s important for investors to know when to cash in before that happens. By hot stocks, Cramer means speculative companies with relatively low market capitalization that are risky, but have the potential for high reward. At first, these stocks…
CNBC Pro Talks: Top strategists and stock pickers share their 2024 market playbook
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email The S&P 500 ended 2023 with a bang, up 24% on the year despite persistent recession warnings, a regional banking crisis, widespread tech layoffs, and ‘higher-for-longer’ interest rates. Can the stock market momentum continue into 2024? Can the rally broaden out past…
AI is in focus at CES: What you need to know
CNBC’s Julia Boorstin joins ‘Power Lunch’ to discuss AI being in focus at CES.
Watch Monday’s full episode of Fast Money — January 8, 2024
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email “Fast Money” is America’s post-market show. Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to bring you the actionable news that matters most to investors. 44:57 Mon, Jan 8 20247:44 PM…
Trump will make a deal with Iran if he gets re-elected, DAMAC chairman says
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email But Hussain Sajwani, chairman of Middle Eastern property development firm DAMAC, says he doesn’t expect President Donald Trump to secure a deal in the Middle East this year. 02:11 Tue, Jan 21 20208:42 AM EST
Shari Redstone launches formal auction of National Amusements: Report
CNBC’s Andrew Ross Sorkin reports on the latest news.
